FDA Adverse Event Injury Summary report: N

OMNIPOD INSULIN MANAGEMENT SYSTEM

MDR report key: 15510707 · Received September 30, 2022

Report

Report Number
3004464228-2022-18151
Event Type
Injury
Date Received
September 30, 2022
Date of Event
September 24, 2022
Report Date
September 28, 2022
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385081120057
PMA / PMN Number
K192659
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE HAS NOT BEEN RETURNED/RECEIVED TO DATE. IF THE DEVICE IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH THE INVESTIGATION RESULTS. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE REPORTED HOSPITALIZATION AND HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.

Additional Manufacturer Narrative · 0

CORRECTION TO D(4): CATALOG NO CHANGED FROM UNAVAILABLE TO ZXP425. CORRECTION TO G(5): PMA/510(K) # CHANGED FROM UNAVAILABLE TO K192659.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT WENT TO THE EMERGENCY ROOM (ER) AND WAS DIAGNOSED WITH BLOOD GLUCOSE (BG) VALUES THAT REACHED 430 MG/DL. FOR TREATMENT, THE PATIENT WAS ADMINISTERED INTRAVENOUS (IV) SALINE. THE POD WAS WORN BETWEEN 4 AND 24 HOURS ON THE ARM. THE PATIENT WAS DISCHARGED AFTER 4 HOURS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1748318 OMNIPOD INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 18025 L71356 20385081120057

Patients

Seq Age Sex Outcome Treatment
1 17 YR Female Required Intervention| H